SEARCH

SEARCH BY CITATION

References

  • 1
    Malliwah JA, Tabaqchali M, Watson J, Venables CW. Audit of the outcome of peptic ulcer disease diagnosed 10–20 years previously. Gut 1996; 38: 812 15.
  • 2
    Penston JG, Dixon JS, Boyd EJS, Wormsley KG. A placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine. Aliment Pharmacol Ther 1993; 7: 259 65.
  • 3
    Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308 12.
  • 4
    Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven year follow-up. Lancet 1994; 343: 258 60.
  • 5
    Fennerty MB. ‘Cure’ of Helicobacter pylori and ‘cure’ of peptic ulcer: do they mean the same thing? Am J Gastroenterol 1995; 90: 1203 4.
  • 6
    Vakil N & Fennerty MB. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. Am J Gastroenterol 1996; 91: 239 45.
  • 7
    Sonnenberg A, Schwartz SJ, Cutler A, Vakil N, Bloom BS. Cost savings in duodenal ulcer treatment through Helicobacter pylori eradication compared to conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group. Arch Intern Med 1998; 158: 852 60.
  • 8
    Phull PS, Ryder SD, Halliday D, Price AB, Levi AJ, Jacyna MR. The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease—a community based study . Postgrad Med J 1995; 71: 413 18.
  • 9
    Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer disease may provoke reflux oesophagitis. Gastroenterology 1997; 112: 1442 7.
  • 10
    Veldhuyzen van Zenten SJO, Tytgat KMAJ, Pollak PT, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis. J Clin Epidemiol 1993; 46: 273 9.
  • 11
    Robinson M, Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux oesophagitis with low dose lansoprazole. Ann Intern Med 1996; 124: 859 67.
  • 12
    Hallerback B, Unge P, Carling L, et al. Omeprazole or ranitidine in long-term treatment of reflux oesophagitis. Gastroenterology 1994; 107: 1305 11.
  • 13
    Johannessen T, Peterson H, Kleveland PM, et al. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25: 689 97.
  • 14
    Nyren O, Adami HO, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339 43.
  • 15
    Phull PS, Halliday D, Price AB, Jacyna MR. Absence of dyspeptic symptoms as a test for Helicobacter pylori eradication. Br Med J 1996; 312: 349 50.
  • 16
    McColl KEL, El-Nujumi A, Murray LS, et al. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer. Gut 1998; 42: 618 22.
  • 17
    Goldman MS, Rasch JR, Wiltsie DS, Finkel M. The incidence of esophagitis in peptic ulcer disease. Am J Dig Dis 1967; 12: 994 9.
  • 18
    Boyd EJS. The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol 1996; 91: 1539 43.
  • 19
    Reilly TG, Ayres RC, Poxon V, Walt RP. Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer. Aliment Pharmacol Ther 1995; 9: 483 90.
  • 20
    Labenz J, Borsch G, Blum A, Bayerdorffer E, Meining A, Stolte M. Reflux esophagitis and Helicobacter pylori. Gastroenterology 1997; 113: 2020 1.
  • 21
    Galmiche JP & Bruley des Varennes S. Symptoms and disease severity in gastro-esophageal reflux disease. Scand J Gastroenterol 1994; 29(Suppl. 201): 62 8.
  • 22
    Johnsson F, Joelsson B, Gudmondsson K, Grieff L. Symptoms and endoscopic findings in the diagnosis of gastro-esophageal reflux disease. Scand J Gastroenterol 1987; 22: 714 18.
  • 23
    Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-esophageal reflux disease. Lancet 1990; 335: 205 8.